Janet Hoek and Philip Gendall
Major tobacco companies have presented a vision of a smokefree world, where smoking prevalence has fallen to minimal levels. This goal has much in common with national tobacco endgame goals and appears to create opportunities for health researchers and smokefree advocates to work collaboratively with a well-resourced industry to achieve a common goal. Yet, despite their public statements, tobacco companies continue to develop new products, such as flavour capsule cigarettes, that enhance smoking’s appeal. This product innovation strategy confirms long-held doubts about the sincerity of tobacco companies’ intentions. We report on our recently published study that examined how flavour capsule cigarettes appeal to non-smokers and smokers.
Dr Lindsay Robertson*
In our recently published work, we studied the impact of the NZ Government preventing new retail outlets from selling tobacco from 2020, while allowing existing retail outlets to continue selling it until they closed or relocated. The estimated outcome would be a 50% decrease in the total number of tobacco retail outlets by 2032. This blog puts these results into the context of tobacco control options for NZ.
Richard Edwards, Anaru Waa, Janet Hoek, Louise Thornley, Nick Wilson.
ASPIRE 2025, Department of Public Health, University of Otago, Wellington
World Smokefree Day is an apt day on which to propose some ideas that may greatly increase momentum for the achieving Smokefree Aotearoa 2025. Tobacco and vaping products such as e-cigarettes vary greatly in their likely adverse health effects and overall impact on population health. Reflecting this, the Ministry of Health announced in May that it will investigate ‘risk-proportionate’ regulation for tobacco and vaping products. This blog discusses public health considerations in developing the new regulatory framework, and proposes key features of a risk-proportionate approach. We argue the framework should aim to minimise harm and maximise benefits to population health by accelerating progress towards New Zealand’s Smokefree 2025 goal. As well as clarifying the appropriate regulatory approaches to vaping products, we see an overwhelming need for much stronger regulation of smoked tobacco products, as these are vastly under-regulated in relation to the harm they cause.
Janet Hoek, Philip Gendall, Richard Edwards, Shayne Nahu, Nick Wilson
From today, all tobacco products in New Zealand will start appearing in standardised, or plain, packages. In this blog, we discuss the importance of developing an on-going monitoring and evaluation plan around this intervention. We also explain why communications with smokers – whether on-pack or mass media – must be salient and timely to have strong and continuing impact on supporting quitting. Achieving all these actions should help to accelerate progress towards the NZ Government’s Smokefree 2025 goal.
Prof Nick Wilson, A/Prof George Thomson
The United States has many major health problems – including declining life expectancy and an exorbitantly expensive health care system. However, the large number of state and local governments provide a wealth of potential lessons that NZ could learn from. In this blog we briefly consider some of these, particularly in the domains of support for nutrition and physical activity, tobacco and alcohol control, and pollution control.